Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Diabetic Foot Ulcers

Trial Information

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

Official Title: A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers

Summary

The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).

Phase: Phase 2

Sponsor: Skingenix, Inc.

Overall Contacts:

Vicki Christodoulou, B.S., M.S.
1-909-587-1650 ext. 1682

Locations (9)

Country State City Zip Facility and Contact
United States Arizona Phoenix 85032 HOPE Research Institute
United States California Castro Valley 94546 Center for Clinical Research, Inc.
United States California Encinitas 92024 ILD Consulting, Inc.
United States California Fair Oaks 95628 Sacramento Foot and Ankle Center
United States California Fresno 93720 Valley Vascular Surgery Associates
United States California Los Angeles 90010 Foot and Ankle Clinic
United States Nevada Las Vegas 89119 Advanced Foot and Ankle Center
United States Texas McAllen 78501 Complete Family Foot Care
United States Texas San Antonio 78229 Endeavor Clinical Trials, San Antonio Podiatry Associates

NCT ID:NCT01070433

Date Last Changed: March 8, 2013